HomeTSHA • NASDAQ
add
Taysha Gene Therapies Inc
Previous close
$1.27
Day range
$1.19 - $1.24
Year range
$1.05 - $4.32
Market cap
244.98M USD
Avg Volume
2.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.02M | -43.90% |
Operating expense | 21.95M | 13.16% |
Net income | -18.78M | -139.35% |
Net profit margin | -929.03 | -170.13% |
Earnings per share | — | — |
EBITDA | -19.63M | -27.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 139.04M | -3.41% |
Total assets | 160.36M | -7.16% |
Total liabilities | 88.84M | -9.16% |
Total equity | 71.52M | — |
Shares outstanding | 205.00M | — |
Price to book | 3.63 | — |
Return on assets | -29.26% | — |
Return on capital | -34.74% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -18.78M | -139.35% |
Cash from operations | -18.31M | -13.59% |
Cash from investing | 13.00K | 230.00% |
Cash from financing | -357.00K | 91.60% |
Net change in cash | -18.65M | 8.46% |
Free cash flow | -11.35M | 92.40% |
About
Founded
2019
Headquarters
Website
Employees
73
